Advertisement
Australia markets closed
  • ALL ORDS

    7,937.50
    -0.40 (-0.01%)
     
  • ASX 200

    7,683.00
    -0.50 (-0.01%)
     
  • AUD/USD

    0.6527
    +0.0027 (+0.42%)
     
  • OIL

    83.18
    +0.37 (+0.45%)
     
  • GOLD

    2,338.70
    +0.30 (+0.01%)
     
  • Bitcoin AUD

    98,062.43
    -4,010.44 (-3.93%)
     
  • CMC Crypto 200

    1,356.72
    -25.85 (-1.87%)
     
  • AUD/EUR

    0.6090
    +0.0019 (+0.32%)
     
  • AUD/NZD

    1.0956
    +0.0015 (+0.13%)
     
  • NZX 50

    11,946.43
    +143.15 (+1.21%)
     
  • NASDAQ

    17,526.80
    +55.33 (+0.32%)
     
  • FTSE

    8,103.00
    +62.62 (+0.78%)
     
  • Dow Jones

    38,460.92
    -42.77 (-0.11%)
     
  • DAX

    18,003.35
    -85.35 (-0.47%)
     
  • Hang Seng

    17,284.54
    +83.27 (+0.48%)
     
  • NIKKEI 225

    37,628.48
    -831.60 (-2.16%)
     

Is There An Opportunity With Sonic Healthcare Limited’s (ASX:SHL) 20.4% Undervaluation?

In this article I am going to calculate the intrinsic value of Sonic Healthcare Limited (ASX:SHL) by taking the expected future cash flows and discounting them to today’s value. This is done using the discounted cash flows (DCF) model. It may sound complicated, but actually it is quite simple! If you want to learn more about discounted cash flow, the basis for my calcs can be read in detail in the Simply Wall St analysis model. If you are reading this and its not November 2018 then I highly recommend you check out the latest calculation for Sonic Healthcare by following the link below.

Check out our latest analysis for Sonic Healthcare

The method

We are going to use a two-stage DCF model, which, as the name states, takes into account two stages of growth. The first stage is generally a higher growth period which levels off heading towards the terminal value, captured in the second ‘steady growth’ period. In the first stage we need to estimate the cash flows to the business over the next five years. For this I used the consensus of the analysts covering the stock, as you can see below. The sum of these cash flows is then discounted to today’s value.

5-year cash flow forecast

2019

2020

2021

2022

2023

Levered FCF (A$, Millions)

A$512.33

A$612.33

A$663.50

A$704.66

A$770.54

Source

Analyst x3

Analyst x3

Analyst x2

Analyst x1

Est @ 9.35%

Present Value Discounted @ 8.55%

A$471.96

A$519.62

A$518.67

A$507.44

A$511.15

Present Value of 5-year Cash Flow (PVCF)= AU$2.5b

ADVERTISEMENT

After calculating the present value of future cash flows in the intial 5-year period we need to calculate the Terminal Value, which accounts for all the future cash flows beyond the first stage. The Gordon Growth formula is used to calculate Terminal Value at an annual growth rate equal to the 10-year government bond rate of 2.8%. We discount this to today’s value at a cost of equity of 8.6%.

Terminal Value (TV) = FCF2022 × (1 + g) ÷ (r – g) = AU$771m × (1 + 2.8%) ÷ (8.6% – 2.8%) = AU$14b

Present Value of Terminal Value (PVTV) = TV / (1 + r)5 = AU$14b ÷ ( 1 + 8.6%)5 = AU$9.1b

The total value, or equity value, is then the sum of the present value of the cash flows, which in this case is AU$12b. To get the intrinsic value per share, we divide this by the total number of shares outstanding, or the equivalent number if this is a depositary receipt or ADR. This results in an intrinsic value of A$27.26. Relative to the current share price of A$21.7, the stock is about right, perhaps slightly undervalued at a 20% discount to what it is available for right now.

ASX:SHL Intrinsic Value Export November 14th 18
ASX:SHL Intrinsic Value Export November 14th 18

Important assumptions

The calculation above is very dependent on two assumptions. The first is the discount rate and the other is the cash flows. If you don’t agree with my result, have a go at the calculation yourself and play with the assumptions. Because we are looking at Sonic Healthcare as potential shareholders, the cost of equity is used as the discount rate, rather than the cost of capital (or weighed average cost of capital, WACC) which accounts for debt. In this calculation I’ve used 8.6%, which is based on a levered beta of 0.800. This is derived from the Bottom-Up Beta method based on comparable companies, with an imposed limit between 0.8 and 2.0, which is a reasonable range for a stable business.

Next Steps:

Whilst important, DCF calculation shouldn’t be the only metric you look at when researching a company. What is the reason for the share price to differ from the intrinsic value? For SHL, I’ve put together three essential factors you should further examine:

  1. Financial Health: Does SHL have a healthy balance sheet? Take a look at our free balance sheet analysis with six simple checks on key factors like leverage and risk.

  2. Future Earnings: How does SHL’s growth rate compare to its peers and the wider market? Dig deeper into the analyst consensus number for the upcoming years by interacting with our free analyst growth expectation chart.

  3. Other High Quality Alternatives: Are there other high quality stocks you could be holding instead of SHL? Explore our interactive list of high quality stocks to get an idea of what else is out there you may be missing!

PS. The Simply Wall St app conducts a discounted cash flow for every stock on the ASX every 6 hours. If you want to find the calculation for other stocks just search here.

To help readers see past the short term volatility of the financial market, we aim to bring you a long-term focused research analysis purely driven by fundamental data. Note that our analysis does not factor in the latest price-sensitive company announcements.

The author is an independent contributor and at the time of publication had no position in the stocks mentioned. For errors that warrant correction please contact the editor at editorial-team@simplywallst.com.